Peter Moosmann

1.2k total citations
23 papers, 938 citations indexed

About

Peter Moosmann is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Molecular Biology. According to data from OpenAlex, Peter Moosmann has authored 23 papers receiving a total of 938 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Pulmonary and Respiratory Medicine, 9 papers in Oncology and 6 papers in Molecular Biology. Recurrent topics in Peter Moosmann's work include Colorectal Cancer Treatments and Studies (5 papers), Gastric Cancer Management and Outcomes (5 papers) and Cancer Treatment and Pharmacology (3 papers). Peter Moosmann is often cited by papers focused on Colorectal Cancer Treatments and Studies (5 papers), Gastric Cancer Management and Outcomes (5 papers) and Cancer Treatment and Pharmacology (3 papers). Peter Moosmann collaborates with scholars based in Switzerland, Germany and United States. Peter Moosmann's co-authors include Oleg Georgiev, W. Schaffner, Jean‐Pierre Bourquin, Bertrand Le Douarin, Beat Frauchiger, Daniel Staub, Hans Peter Schmid, Walter Schaffner, Hans‐Jürgen Thiesen and Michael Hagmann and has published in prestigious journals such as Nucleic Acids Research, Journal of Clinical Oncology and Blood.

In The Last Decade

Peter Moosmann

23 papers receiving 917 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Peter Moosmann Switzerland 15 392 264 237 138 110 23 938
Phillippa J. Neville United States 11 284 0.7× 215 0.8× 277 1.2× 99 0.7× 158 1.4× 11 787
Seon‐Hee Yim South Korea 20 457 1.2× 288 1.1× 193 0.8× 136 1.0× 282 2.6× 41 1.2k
Hiroaki Ohnishi Japan 16 291 0.7× 274 1.0× 256 1.1× 49 0.4× 45 0.4× 52 774
Sunita Badola United States 9 207 0.5× 233 0.9× 131 0.6× 60 0.4× 123 1.1× 16 729
Peter Schirmacher Germany 15 193 0.5× 188 0.7× 146 0.6× 173 1.3× 83 0.8× 52 723
Ivan Ngai United States 13 496 1.3× 266 1.0× 92 0.4× 118 0.9× 105 1.0× 22 819
Mario Budroni Italy 19 442 1.1× 532 2.0× 223 0.9× 111 0.8× 188 1.7× 49 1.2k
Darlene Gibbon United States 15 375 1.0× 325 1.2× 115 0.5× 65 0.5× 36 0.3× 38 834
Barbara L. Bane United States 14 177 0.5× 106 0.4× 372 1.6× 194 1.4× 119 1.1× 22 855
Kevin W. O’Connor United States 13 810 2.1× 563 2.1× 229 1.0× 407 2.9× 217 2.0× 25 1.5k

Countries citing papers authored by Peter Moosmann

Since Specialization
Citations

This map shows the geographic impact of Peter Moosmann's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peter Moosmann with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peter Moosmann more than expected).

Fields of papers citing papers by Peter Moosmann

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Peter Moosmann. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peter Moosmann. The network helps show where Peter Moosmann may publish in the future.

Co-authorship network of co-authors of Peter Moosmann

This figure shows the co-authorship network connecting the top 25 collaborators of Peter Moosmann. A scholar is included among the top collaborators of Peter Moosmann based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Peter Moosmann. Peter Moosmann is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Siebenhüner, Alexander, Sara De Dosso, Daniel Helbling, et al.. (2021). Advanced Gastric Cancer: Current Treatment Landscape and a Future Outlook for Sequential and Personalized Guide: Swiss Expert Statement Article. Oncology Research and Treatment. 44(9). 485–494. 21 indexed citations
3.
Rothschild, Sacha I., Daniel Betticher, Sandro Anchisi, et al.. (2019). Prospective, observational practice survey of applied skin care and management of cetuximab-related skin reactions: PROSKIN study. Cancer Chemotherapy and Pharmacology. 84(4). 881–889. 6 indexed citations
4.
Quagliata, Luca, Mariacarla Andreozzi, Serenella Eppenberger‐Castori, et al.. (2017). Vascular endothelial growth factor A amplification in colorectal cancer is associated with reduced M1 and M2 macrophages and diminished PD-1-expressing lymphocytes. PLoS ONE. 12(4). e0175563–e0175563. 15 indexed citations
5.
Behringer, Karolin, Helen Goergen, Horst Müller, et al.. (2016). Cancer-Related Fatigue in Patients With and Survivors of Hodgkin Lymphoma: The Impact on Treatment Outcome and Social Reintegration. Journal of Clinical Oncology. 34(36). 4329–4337. 62 indexed citations
6.
7.
Koeberle, Dieter, Daniel Betticher, Roger von Moos, et al.. (2013). Bevacizumab Continuation Versus No Continuation After First-Line Chemo-Bevacizumab Therapy in Patients with Metastatic Colorectal Cancer: a Phase 3 Non-Inferiority Trial. Annals of Oncology. 24. iv22–iv22. 1 indexed citations
8.
Koeberle, Dieter, Daniel Betticher, Roger von Moos, et al.. (2013). Bevacizumab continuation versus no continuation after first-line chemo-bevacizumab therapy in patients with metastatic colorectal cancer: A randomized phase III noninferiority trial (SAKK 41/06).. Journal of Clinical Oncology. 31(15_suppl). 3503–3503. 20 indexed citations
9.
Ribi, Karin, Dieter Koeberle, Jan C. Schuller, et al.. (2009). Is a change in patient-reported dysphagia after induction chemotherapy in locally advanced esophageal cancer a predictive factor for pathological response to neoadjuvant chemoradiation?. Supportive Care in Cancer. 17(8). 1109–1116. 18 indexed citations
10.
Heizmann, Marc, Alix O’Meara, Peter Moosmann, et al.. (2009). Efficient mobilization of PBSC with vinorelbine/G-CSF in patients with malignant lymphoma. Bone Marrow Transplantation. 44(2). 75–79. 14 indexed citations
11.
12.
Niederwieser, Dietger, Chiara Gentilini, Ute Hegenbart, et al.. (2004). Transmission of donor illness by stem cell transplantation: should screening be different in older donors?. Bone Marrow Transplantation. 34(8). 657–665. 40 indexed citations
13.
Pichert, Gabriella, Daniel Dietrich, Peter Moosmann, et al.. (2003). Swiss primary care physicians' knowledge, attitudes and perception towards genetic testing for hereditary breast cancer. Familial Cancer. 2(3-4). 153–158. 32 indexed citations
14.
Moosmann, Peter, F Egli, Rolf A. Stahel, & L.M. Jost. (2003). Weekly Paclitaxel and Carboplatin Combination Chemotherapy in Patients with Advanced Squamous Cell Carcinoma of the Head and Neck. Oncology Research and Treatment. 26(6). 568–572. 23 indexed citations
15.
Moosmann, Peter, Jean‐Claude Fauchère, Jörg Halter, David C. Binder, & Urs Schanz. (2000). [Neonatal alloimmune thrombocytopenia due to a rare anti-HPA-1b antibody].. PubMed. 130(45). 1734–7. 1 indexed citations
16.
Moosmann, Peter, et al.. (2000). Hyperventilation due to mitochondrial myopathy. Journal of the Royal Society of Medicine. 93(1). 25–26. 1 indexed citations
17.
Kleinle, Stephanie, Volker Schneider, Peter Moosmann, et al.. (1998). A Novel Mitochondrial tRNAPheMutation Inhibiting Anticodon Stem Formation Associated with a Muscle Disease. Biochemical and Biophysical Research Communications. 247(1). 112–115. 33 indexed citations
18.
Moosmann, Peter, Oleg Georgiev, Hans‐Jürgen Thiesen, Michael Hagmann, & Walter Schaffner. (1997). Silencing of RNA Polymerases II and III-Dependent Transcription by the KRAB Protein Domain of KOX1, a Krüppel-Type Zinc Finger Factor. Biological Chemistry. 378(7). 669–77. 77 indexed citations
19.
Moosmann, Peter, Oleg Georgiev, Bertrand Le Douarin, Jean‐Pierre Bourquin, & W. Schaffner. (1996). Transcriptional Repression by RING Finger Protein TIF1  That Interacts with the KRAB Repressor Domain of KOX1. Nucleic Acids Research. 24(24). 4859–4867. 253 indexed citations
20.
Moosmann, Peter. (1996). Alpha complementation of LacZ in mammalian cells. Nucleic Acids Research. 24(6). 1171–1172. 49 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Phillippa J. Neville Breakdown of academic impact, for papers by Seon‐Hee Yim Breakdown of academic impact, for papers by Hiroaki Ohnishi Breakdown of academic impact, for papers by Sunita Badola Breakdown of academic impact, for papers by Peter Schirmacher Breakdown of academic impact, for papers by Ivan Ngai Breakdown of academic impact, for papers by Mario Budroni Breakdown of academic impact, for papers by Darlene Gibbon Breakdown of academic impact, for papers by Barbara L. Bane Breakdown of academic impact, for papers by Kevin W. O’Connor
Rankless by CCL
2026